The Global Burden of Disease Study (GBD), coordinated by the Institute of Health Metrics and Evaluation (IHME), provides estimates of cause-related disability and loss of life at national and subnational levels.
Members of the Independent Advisory Committee to the Global Burden of Disease, including Kim Longfield from PSI, contributed a comment to the Lancet highlighting the need for comprehensive and consistent estimates to support decision-making and priority-setting in public health.